Universal Cells
Brooke Barnett has experience working as a Research Associate I at Universal Cells, specializing in clinical gene editing. Prior to this, Brooke worked as an Undergraduate Researcher at Purdue University, focusing on developing elastin-like polypeptide fusion proteins for imaging non-muscle invasive bladder cancer. Brooke also served as a Teaching Intern for First-Year Biology Laboratory, a Clerical Assistant at Bindley Bioscience Center, and conducted research on epithelial cells and neutrophils in the rat estrous cycle. Additionally, Brooke has experience working as a Grocery Associate/Cashier at Fresh Thyme Farmers Market. Brooke holds a Bachelor of Science degree in Biochemistry from Purdue University.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.